ICOSLG Antikörper (AA 197-246)
Kurzübersicht für ICOSLG Antikörper (AA 197-246) (ABIN6749802)
Target
Alle ICOSLG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 197-246
-
Marke
- IHC-plus™
-
Spezifität
- Human ICOSLG / ICOSL
-
Homologie
- Percent identity by BLAST analysis: Human (100%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa197-246 of human ICOSLG (O75144, NP_056074). Percent identity by BLAST analysis: Human, Gorilla (100%), Gibbon, Monkey (92%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Approved: IHC, IHC-P (5 - 10 μg/mL), WB
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
: "Osteopontin binds ICOSL promoting tumor metastasis." in: Communications biology, Vol. 3, Issue 1, pp. 615, (2020) (PubMed).
-
: "Osteopontin binds ICOSL promoting tumor metastasis." in: Communications biology, Vol. 3, Issue 1, pp. 615, (2020) (PubMed).
-
- ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Andere Bezeichnung
- ICOSLG / ICOSL / ICOS Ligand
-
Hintergrund
-
Name/Gene ID: ICOSLG
Synonyms: ICOSLG, B7RP1, B7 homolog 2, B7 homologue 2, B7-H2, B7H2, B7RP-1, CD275 antigen, ICOS ligand, GL50, ICOS-L, ICOSL, KIAA0653, B7-like protein Gl50, B7-related protein 1, CD275, LICOS -
Gen-ID
- 23308
-
NCBI Accession
- NP_056074
-
UniProt
- O75144
-
Pathways
- Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Target
-